Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

824
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
824
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

772
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

841
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
841
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

732
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

661
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
661
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

534
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
534

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Respiratory Failure and Mechanical Ventilation in Women With COVID-19 During Pregnancy: Best Clinical Practices.

The Journal of perinatal & neonatal nursing·2022
Same author

Physiologic and Hemodynamic Changes During Pregnancy.

AACN advanced critical care·2018
Same author

Maternal Mortality and Morbidity in the United States: Classification, Causes, Preventability, and Critical Care Obstetric Implications.

The Journal of perinatal & neonatal nursing·2018
Same author

Morbidly Adherent Placenta: Interprofessional Management Strategies for the Intrapartum Period.

The Journal of perinatal & neonatal nursing·2016
Same author

Burn injuries and pregnancy.

The Journal of perinatal & neonatal nursing·2008
Same author

Mechanical ventilation in an obstetric population: characteristics and delivery rates.

American journal of obstetrics and gynecology·2003

Related Experiment Video

Updated: Apr 6, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.5K

Cardiomyopathy During Pregnancy.

Nan H Troiano1

  • 1Director, Women's and Infants' Services, Sibley Memorial Hospital, Johns Hopkins Medicine, Washington, District of Columbia.

The Journal of Perinatal & Neonatal Nursing
|July 29, 2015
PubMed
Summary

Cardiomyopathy during pregnancy, though rare, is a serious condition. This review covers peripartum cardiomyopathy and other types, highlighting risks and management for mothers and babies.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Maternal-Fetal Medicine

Background:

  • Cardiomyopathy is an acquired heart condition increasingly implicated in pregnancy-related deaths.
  • It presents diagnostic and management challenges during the perinatal period.
  • Understanding its impact is crucial for maternal and fetal outcomes.

Purpose of the Study:

  • To review the types of cardiomyopathy occurring during pregnancy.
  • To outline the associated perinatal risks.
  • To discuss general management principles, emphasizing intrapartum care.

Main Methods:

  • Literature review of cardiomyopathy in pregnancy.
  • Categorization of cardiomyopathy into peripartum and other pathophysiologic types (hypertrophic, dilated, restrictive).

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.5K
Noninvasive Electrocardiography in the Perinatal Mouse
04:36

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

6.9K

Related Experiment Videos

Last Updated: Apr 6, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.5K
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.5K
Noninvasive Electrocardiography in the Perinatal Mouse
04:36

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

6.9K
  • Presentation of hemodynamic and oxygen transport data for assessment and intervention illustration.

    • Main Results:

    • Cardiomyopathy during pregnancy poses significant morbidity and mortality risks.
    • Peripartum cardiomyopathy is a distinct entity.
    • Other types include hypertrophic, dilated, and restrictive cardiomyopathies, which can be idiopathic or secondary.

    Conclusions:

    • Prompt diagnosis and management of cardiomyopathy are vital in pregnancy.
    • Specialized care focusing on hemodynamic stability is essential during labor and delivery.
    • Further research into specific management strategies can improve maternal and fetal survival rates.